Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
News about 'NurOwn' stem cell therapy, nutrition and respiratory complications, vitamin E, the growth factor G-CSF, and low-dose naltrexone
Posted on Thursday, May 19, 2011 - 15:17, By: Amy Madsen
NurOwn stem cell therapy trial set to begin
Biotechnology company Brainstorm Cell Therapeutics announced May 17, 2011, that it has received approval from Israel's Ministry of Health to conduct a phase 1-2 clinical trial of stem cell therapy in adults with ALS (amyotrophic lateral sclerosis, or Lou...
Posted on Friday, August 1, 2003 - 13:20, By: Margaret Wahl
Long-term NIV success
Ed White knows a lot about assisted ventilation in ALS, a disease he’s had for 11 years. For eight years, he’s breathed with the help of a noninvasive ventilation (NIV) system.
Posted on Sunday, September 1, 2002 - 12:44, By: ALSN Staff
Weakness of the muscles that control or influence breathing or swallowing is by far the most serious problem in ALS and requires decisions about whether and how to prolong life.
Posted on Sunday, April 1, 2001 - 07:00, By: ALSN Staff
MDA/ALS Center Director recommends better planning
Using a noninvasive ventilation device in ALS may actually weaken respiratory muscles faster than not using one, a preliminary study in the March issue of Muscle & Nerve suggests. On the other hand, the use of such devices was found by the...
Posted on Tuesday, August 1, 2000 - 17:00, By: Other
Edward Sivak is a professor of medicine and a pulmonologist associated with the MDA/ALS Center at the State University of New York in Syracuse.